Skip to content

Personalis, Inc. PSNL Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$65M+124%
NeoGenomics logo
NeoGenomicsNEO
-$338K-136%
Illumina logo
IlluminaILMN
$24M-11.1%
Veracyte logo
VeracyteVCYT
$2.74M-7.8%
Guardant Health logo
Guardant HealthGH
$3.65M+375%
Natera, Inc. logo
Natera, Inc.NTRA
$3.86M+610%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s stock issuance proceeds?
Personalis, Inc. (PSNL) reported stock issuance proceeds of $20.95M in Q1 2026.
How has Personalis, Inc.'s stock issuance proceeds changed year-over-year?
Personalis, Inc.'s stock issuance proceeds increased by 17.8% year-over-year, from $17.78M to $20.95M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.